Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens

Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens

US Patent 9095578 · Granted Aug 4, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of soluble adenylyl cyclase2021
Inhibitors of soluble adenylyl cyclase2021
Method for processing additively manufactured part by robotically moving medium 2019
Chemical inhibitors of soluble adenylyl cyclase (sAC)2017
Chemical inhibitors of soluble adenylyl cyclase (sAC)2017
Method to treat psoriasis and other hyperproliferative skin disorders2016
Method to treat psoriasis and other hyperproliferative skin disorders2016
Adenylyl cyclases as novel targets for antibactrial interventions2015
Adenylyl cyclases as novel targets for antibactrial interventions2015
Adenylyl cyclases as novel targets for antibactrial interventions2015
Adenylyl cyclases as novel targets for antibactrial interventions2015
Method for diagnosing melanocytic proliferations2014